
GBS GBS
Quartalsbericht 2025-Q4
hinzugefügt 12.02.2026
Land |
|
IPO-Jahr |
2020 |
Branche |
Medizinische Geräte |
Börse |
NASDAQ GLOBAL |
Anteile |
5.27 M |
Marktkapitalisierung |
$ 7.12 M |
EBITDA (LTM) |
$ -9.31 M |
P/E (LTM) |
- |
P/S (LTM) |
2.02 |
EPS (LTM) |
-8.57 |
Andere Aktien der Branche "Medizinische Geräte"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Alphatec Holdings
ATEC
|
$ 14.04 | - | $ 2.11 B | Nasdaq Global Select Market | ||
|
Cognyte Software Ltd.
CGNT
|
$ 6.62 | - | $ 475 M | Nasdaq Global Select Market,SPB | ||
|
ClearPoint Neuro
CLPT
|
$ 15.16 | - | $ 410 M | Nasdaq Capital Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
AxoGen
AXGN
|
$ 31.22 | - | $ 1.44 B | Nasdaq Capital Market,SPB | ||
|
EDAP TMS S.A.
EDAP
|
$ 4.59 | 2.68 % | $ 171 M | Nasdaq Global Market | ||
|
Electromed
ELMD
|
$ 23.92 | - | $ 202 M | NYSE American | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Apyx Medical Corporation
APYX
|
$ 3.42 | - | $ 118 M | Nasdaq Global Select Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Bio-Rad Laboratories
BIO
|
$ 269.65 | - | $ 7.61 B | NYSE,SPB | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Bruker Corporation
BRKR
|
$ 39.89 | - | $ 5.94 K | Nasdaq Global Select Market,SPB | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Boston Scientific Corporation
BSX
|
$ 73.48 | - | $ 109 B | NYSE,SPB | ||
|
InMode Ltd.
INMD
|
$ 13.96 | - | $ 902 M | Nasdaq Global Select Market,SPB | ||
|
IRadimed Corporation
IRMD
|
$ 100.5 | - | $ 1.27 B | Nasdaq Global Select Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
LivaNova PLC
LIVN
|
$ 70.29 | - | $ 3.83 B | Nasdaq Global Select Market | ||
|
CONMED Corporation
CNMD
|
$ 45.98 | - | $ 1.43 B | NYSE,SPB | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Medtronic PLC
MDT
|
$ 96.65 | - | $ 124 B | NYSE,SPB | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
MiMedx Group
MDXG
|
$ 5.28 | -1.31 % | $ 780 M | Nasdaq Global Select Market | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
Delcath Systems
DCTH
|
$ 10.21 | - | $ 291 M | Nasdaq Capital Market | ||
|
Nano-X Imaging Ltd.
NNOX
|
$ 2.45 | - | $ 144 M | Nasdaq Global Select Market | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Insulet Corporation
PODD
|
$ 248.12 | - | $ 17.5 B | Nasdaq Global Select Market,SPB | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Establishment Labs Holdings
ESTA
|
$ 78.29 | - | $ 2.2 B | Nasdaq Capital Market | ||
|
Quanterix Corporation
QTRX
|
$ 6.29 | - | $ 236 M | Nasdaq Global Select Market,SPB | ||
|
FONAR Corporation
FONR
|
$ 18.58 | - | $ 122 M | Nasdaq Capital Market | ||
|
Sintx Technologies
SINT
|
$ 2.94 | - | $ 11 M | Nasdaq Capital Market | ||
|
Smith & Nephew plc
SNN
|
$ 36.29 | - | $ 23.8 B | NYSE |